0001104659-24-043618.txt : 20240404 0001104659-24-043618.hdr.sgml : 20240404 20240404160346 ACCESSION NUMBER: 0001104659-24-043618 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240404 DATE AS OF CHANGE: 20240404 EFFECTIVENESS DATE: 20240404 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iBio, Inc. CENTRAL INDEX KEY: 0001420720 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 262797813 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-509717 FILM NUMBER: 24823118 BUSINESS ADDRESS: STREET 1: 600 MADISON AVENUE, SUITE 1601 CITY: NEW YORK STATE: NY ZIP: 10022-1737 BUSINESS PHONE: 302 355-0650 MAIL ADDRESS: STREET 1: 600 MADISON AVENUE, SUITE 1601 CITY: NEW YORK STATE: NY ZIP: 10022-1737 FORMER COMPANY: FORMER CONFORMED NAME: iBioPharma, Inc. DATE OF NAME CHANGE: 20080806 FORMER COMPANY: FORMER CONFORMED NAME: InB:Biotechnologies, Inc. DATE OF NAME CHANGE: 20071210 D 1 primary_doc.xml X0708 D LIVE 0001420720 iBio, Inc. 8800 HSC PARKWAY BRYAN TX TEXAS 77807 (979) 446-0027 DELAWARE None iBioPharma, Inc. InB:Biotechnologies, Inc. Corporation true Martin Brenner 8800 HSC Parkway Bryan TX TEXAS 77807 Executive Officer Felipe Duran 8800 HSC Parkway Bryan TX TEXAS 77807 Executive Officer Evert Shimmelpennink 8800 HSC Parkway Bryan TX TEXAS 77807 Director Linda Armstrong 8800 HSC Parkway Bryan TX TEXAS 77807 Director Alexandra Kropotova 8800 HSC Parkway Bryan TX TEXAS 77807 Director William Clark 8800 HSC Parkway Bryan TX TEXAS 77807 Director Gary Sende 8800 HSC Parkway Bryan TX TEXAS 77807 Director James Hill 8800 HSC Parkway Bryan TX TEXAS 77807 Director Biotechnology Decline to Disclose 06b false 2024-03-26 false true true true Warrants and Pre-Funded Warrants false 0 Chardan Capital Markets LLC 000120128 None None 17 State Street, Suite 2130 New York NY NEW YORK 10020 GA GEORGIA MA MASSACHUSETTS NY NEW YORK TX TEXAS PR PUERTO RICO false 15068745 15068745 0 false 8 794124 true 0 0 true While no offering proceeds are set aside for payments to named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers. false iBio, Inc. /s/ Martin Brenner Martin Brenner Chief Executive Officer 2024-04-03